Bisoprolol + Candesartan
Benefits at a glance
- With this combination we covering two indications - heart failure and hypertension - with one tablet
- Combined administration of the drug classes is recommended in relevant guidelines and co-prescribing data confirm frequent co-medication
- Literature based evidence and recommendation
Product details
Indication
Strengths
5.0mg + 8.0mg
2.5mg + 16.0mg
5.0mg + 16.0mg
5.0mg + 32.0mg
Dosage form
API
Regulatory approach
Substitution of both mono substances
Dossier available
Turnover
Development by
Summary
With our new fixed dose combination, we have combined two established active ingredients used for the treatment of high blood pressure and hypertension (selective β₁-adrenoreceptor blocker + angiotensin II receptor antagonists).
The treatment guidelines support the combination of bisoprolol and candesartan. Together with co-prescribing data and literature-based clinical evidence, this new fixed dose combination offers an innovative and patient-friendly treatment option.
It delivers the required medication while reducing the number of single tablets patients need to take. This improves patient satisfaction and quality of life in the long term.
Your Contact
Heike Sagi
Business Development & Licensing
Senior Director
Rheinstraße 49
55218 Ingelheim
Germany
-
Disclaimer
The exploitation, including the development, sale and offer for sale of products and related processes is performed by Midas only in those territories where permissible by applicable patent law in particular, but not limited to EC Directive 2001/83 EC, Article 10, as amended by EC Directive 2004/27 EC. This document, therefore, does not and shall not constitute an offer for sale for the product in territories where an offer for sale or sale is not permissible by law. Midas expressly disclaims any liability for the information provided in this document as well as for damages resulting from or arising out of the use of the product and related process for purposes other than research and development in compliance with applicable laws.